Add time:09/05/2019         Source:sciencedirect.com

ObjectiveTiotropium is a long-acting muscarinic antagonist approved for maintenance treatment of asthma in children, adolescents, and adults in the United States, and recommended as add-on treatment for uncontrolled asthma despite treatment with inhaled corticosteroids and/or long-acting beta-2 agonists. This review traces the journey of tiotropium from its historical origins through early preclinical testing to human clinical trials and real-life studies.

We also recommend Trading Suppliers and Manufacturers of Tiotropium bromide (cas 136310-93-5). Pls Click Website Link as below: cas 136310-93-5 suppliers